Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Cash from Investing Activities (2020 - 2025)

Cytek Biosciences' Cash from Investing Activities history spans 6 years, with the latest figure at -$1.8 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 97.1% year-over-year to -$1.8 million; the TTM value through Dec 2025 reached $10.1 million, up 112.19%, while the annual FY2025 figure was $10.1 million, 112.19% up from the prior year.
  • Cash from Investing Activities reached -$1.8 million in Q4 2025 per CTKB's latest filing, down from $18.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $43.1 million in Q3 2023 to a low of -$168.9 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$12.2 million, with a median of -$1.3 million recorded in 2021.
  • The largest YoY upside for Cash from Investing Activities was 3849.91% in 2023 against a maximum downside of 21550.51% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$18.3 million in 2021, then tumbled by 179.1% to -$51.1 million in 2022, then soared by 156.92% to $29.1 million in 2023, then tumbled by 318.24% to -$63.4 million in 2024, then skyrocketed by 97.1% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Cash from Investing Activities are -$1.8 million (Q4 2025), $18.9 million (Q3 2025), and -$16.4 million (Q2 2025).